Skip to main content
. 2022 Oct 5;11(19):5882. doi: 10.3390/jcm11195882

Figure 2.

Figure 2

Prevalence of antidepressant use in inpatients hospitalized with and without COVID-19 (N = 82,586). (A) prevalence of antidepressant use in a matched analytic sample of inpatients with and without COVID-19, based on age, sex, hospital, period of hospitalization, and number of medical conditions; (B) association between antidepressant use and SARS-CoV-2 infection in a matched analytic sample of inpatients with and without COVID-19, stratified by age, sex, period of hospitalization, and any current diagnosis of psychiatric disorder; (C) comparison of antidepressant use with statin use, and fluoxetine or fluvoxamine use with atorvastatin use, in a matched analytic sample of inpatients with and without COVID-19; (D) associations across antidepressant classes.